PLK1 and anemia (phenotype): In this study, we explored the mechanisms of PLK1 inhibitor-induced anemia using Volasertib (BI6727) and GSK461364, two well-known clinical PLK1 inhibitors (Fernández-Sainz et al., 2023; Van den Bossche et al., 2016).